Edit |   |
---|---|
Antigenic Specificity | Zaire Ebola Virus (Atoltivimab biosimilar) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | Protein A/G purified |
Size | 100 µg, 1 mg, |
Concentration | typically between 0.5-2.0 mg/ml. |
Applications | ELISA, WB |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Atoltivimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting Zaire Ebola Virus, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Atoltivimab can target Ebola virus and is expected to be used for post-exposure prevention of this deadly virus. |
Immunogen | n/a |
Other Names | Atoltivimab, Zaire Ebola Virus, 2135632-29-8 |
Gene, Accession # | CAS: 2135632-29-8 |
Catalog # | abx831529 |
Price | please inquire |
Order / More Info | Zaire Ebola Virus (Atoltivimab biosimilar) Antibody from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950